It’s been eight months since the Moderna vaccine was approved by the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA), the second of three vaccines given EUA in the U.S. So by now, anyone who’s gotten inoculated or plans to do so likely knows the side effects that come with the COVID vaccine: symptoms like pain at the injection site, fatigue, headache, muscle and joint pain, fever, nausea, vomiting, and diarrhea. But in recent months, a growing number of incidences of one side effect have been reported, and now, the FDA and Centers for Disease Control and Prevention (CDC) are reportedly looking into whether or not Moderna is more often linked to it. Read on to find out the latest.
The Washington Post reports that the CDC and FDA are looking at data that suggests that Moderna’s COVID-19 vaccine may be linked to a higher risk of heart inflammation—also known as myocarditis and pericarditis—in young adults as compared to the Pfizer vaccine.
The CDC and FDA review is reportedly based on data from Canada and is still being evaluated by scientific authorities, but two people familiar with the study told the Post that Moderna has been linked with increased cases of myocarditis, inflammation of the heart, and pericarditis, inflammation of the tissue around the heart. According to one of the newspaper’s sources, who spoke on the condition of anonymity, the Canadian report “indicates there might be a 2-½ times higher incidence of myocarditis in those who get Moderna compared with the Pfizer-BioNTech vaccine.” Canadian figures are also grim:
However, the anonymous source went on to say that researchers have yet to come to a conclusion about the side effect’s link to Moderna specifically. “The data are not slam bang,” they said.
Scientists have known for months that the mRNA vaccines, Moderna and Pfizer, have a possible link to myocarditis and pericarditis. In June, the CDC reported that its Vaccine Adverse Event Reporting System (VAERS) had logged more than a thousand calls to its hotline of cases of myocarditis and pericarditis following vaccination. VAERS logs self-reports of adverse vaccine effects and is not vetted by medical professionals. The bulk of the cases reported at that time occurred in young men between the ages of 16 and 30, and happened after their second dose. Patients reported feeling the effects within several days of the vaccination.
The VAERS report aligns with the European Medicines Agency data, which reviews COVID-19 treatment across the entire European economic area. A July report from the EMA found cases of myocarditis and pericarditis in both people who got the Moderna and Pfizer jabs. The agency found 145 cases of myocarditis and 138 cases of pericarditis out of 177 million doses of Pfizer (called Comirnaty in the E.U.). It recorded 19 cases of myocarditis and 19 cases of pericarditis among 20 million Moderna (called Spikevax in the E.U.) jabs. Among all reported cases of myocarditis and pericarditis, five resulted in death. (However latest figures as of 14/08/2021, show much higher: 22,132 Cardiac disorders incl. 1,591 deaths –@monarchofangels) @https://bittube.tv/post/65dea31d-e93a-47d7-9c0b-a9e05a8c79d6 & https://healthimpactnews.com/2021/21766-dead-over-2-million-injured-50-serious-reported-in-european-unions-database-of-adverse-drug-reactions-for-covid-19-shots/
Those numbers, according to the EMA, are not statistically significant, all amounting to less than .00008 percent of recipients effected.
Current VAERS Figures: USA
The last VAERS report from this past weekend listed:
- 12,791 deaths
- 16,044 permanent disabilities
- 70,667 emergency room visits
- 51,242 hospitalizations
- 13,139 life threatening events
following COVID-19 shots.